SCHEMBL29464313

SCHEMBL29464313

Cc1c(F)cccc1-c1nc(NS(=O)(=O)c2cccc(N)n2)ccc1C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.35
MPL P40238 1/20 0.33
SCN1A P35498 3/20 0.33
SCN8A Q9UQD0 3/20 0.33
SCN9A Q15858 2/20 0.32
SCN5A Q14524 2/20 0.32
KIF11 P52732 1/20 0.32
EIF2AK3 Q9NZJ5 3/20 0.32
SLC40A1 Q9NP59 2/20 0.31
SLC22A12 Q96S37 1/20 0.31
KMO O15229 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19925087 1.00 HSD11B1 (0.35) HSD11B1MPLSCN1ASCN8ASCN9A
SCHEMBL29464850 0.90 SCN1A (0.38) HSD11B1SCN1ASCN8ASCN5A
SCHEMBL19925692 0.90 SCN1A (0.38) HSD11B1SCN1ASCN8ASCN5A
SCHEMBL19927703 0.88 HSD11B1 (0.37) HSD11B1MPLSCN9ASLC40A1SLC22A12
SCHEMBL29464412 0.88 HSD11B1 (0.37) HSD11B1MPLSCN9ASLC40A1SLC22A12
SCHEMBL19928762 0.86 HSD11B1 (0.38) HSD11B1SCN1ASCN8ASCN9ASCN5A
SCHEMBL29464516 0.86 HSD11B1 (0.38) HSD11B1SCN1ASCN8ASCN9ASCN5A
SCHEMBL19968760 0.86 PTPN1 (0.37) HSD11B1MPLSCN9ASLC40A1SLC22A12
SCHEMBL29464335 0.86 PTPN1 (0.37) HSD11B1MPLSCN9ASLC40A1SLC22A12
SCHEMBL19925226 0.84 PKM (0.36) HSD11B1MPLSCN1ASCN8ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641873-B N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease 诺华股份有限公司 2022-03-18 CN claimed
CN-109641873-B N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease 诺华股份有限公司 2022-03-18 CN disclosed